Do you want to read an article? Please log in or register.
Spanish Consensus on the Diagnosis and Management of Patients With Activated PI3K Delta Syndrome (APDS)
Further Publications Immunology
Indications
Related content
Further Publications Immunology
Comparative efficacy of leniolisib (CDZ173) versus standard of care on rates of respiratory tract infection and serum immunoglobulin M (IgM) levels among individuals with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): An externally-controlled study
Clin Exp Immunol
Whalen J, Chandra A, Kracker S, Ehl S, Seidel MG, Gulas I, Dron L, Velummailum R, Nagamuthu C, Liu S, Tutein Nolthenius J, Maccari ME, European Society for Immunodeficiencies (ESID)-APDS Registry Working Party
doi: 10.1093/cei/uxae107
Immunodeficiency
A randomised, placebo-controlled, phase III trial of leniolisib in activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS): Adolescent and adult subgroup analysis
Clin Immunol
Rao VK, Šedivá A, Dalm VASH, Plebani A, Schuetz C, Shcherbina A, Trizzino A, Zharankova Y, Orpia A, Kulm E, Webster S, Körholz J, Lougaris V, Rodina Y, Conlon N, Coulter T, Bradt J, Relan A, Uzel G
doi: 10.1016/j.clim.2024.110400
Autoimmune Disease
Disease activity in patients with idiopathic inflammatory myopathy according to time since diagnosis and positivity to antisynthetase autoantibodies: data from the Myo-Spain registry
Arthritis Res Ther
Cobo-Ibáñez T, Castellví I, Pros A, Domínguez-Álvaro M, Nuño-Nuño L, Martínez-Barrio J, Jovaní V, Romero-Bueno F, Ruiz-Lucea E, Tomero E, Trallero-Araguás E, Narváez J, Camins-Fàbregas J, Ruiz-Román A, Loarce-Martos J, Holgado-Pérez S, Flores-Rodríguez VM, Sivera F, Merino-Argumanez C, Juan-Mas A, Altabás-González I, Martín-López M, Belzunegui-Otano JM, Carrasco-Cubero C, Freire-González M, Rúa-Figueroa I, Lozano-Rivas N, Suarez-Cuba JD, Martínez O, Ortega-Castro R, Alcocer P, Gómez-Gómez A, Sánchez-Pernaute O, Tandaipan JL, Carrión-Barberà I, Plasencia-Rodríguez C, Ibarguengoitia-Barrena O, Vidal-Montal P, Ortiz-Santamaria V, Garrido-Puñal N, Riveros A, Delgado-Frías E, López-Gómez JM, Barbadillo C, Pego-Reigosa JM, Joven-Ibáñez BE, Valero-Jaimes JA, Naveda E, Turrión-Nieves AI, Seoane-Mato D, Prado-Galbarro FJ, Puche-Larrubia MÁ
doi: 10.1186/s13075-024-03471-x
Further Publications Rheumatology
Systematic literature review informing the EULAR points to consider for patient education in physical activity and self-management of pain during transitional care
Ann Rheum Dis
Courel-Ibáñez J, Prieto-Moreno R, Briones-Vozmediano E, Ariza-Vega P, Angevare S, Anton J, Bini I, Clemente D, Correia M, Costello W, De Cock D, Domjan A, Leon L, Marques A, Minden K, Mourão AF, Najm A, Özen S, Pimentel G, Saleem Z, Vetrovsky T, Wulffraat N, Zacarias A, Prior Y, Carmona L, Estévez-López F
doi: 10.1016/j.ard.2025.01.017
Further Publications Immunology
Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease
Ann Rheum Dis
Bindoli S, De Matteis A, Mitrovic S, Fautrel B, Carmona L, De Benedetti F
doi: 10.1136/ard-2024-225854
Psoriatic Arthritis
Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies
Ther Adv Musculoskelet Dis
Kristensen LE, Tillett W, Nash P, Coates LC, Mease PJ, Ogdie A, Gisondi P, Ink B, Prickett AR, Bajracharya R, Taieb V, Lyris N, Lambert J, Walsh JA
doi: 10.1177/1759720X241288071
Further Publications Immunology
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study
Lancet
Ferrante M, D'Haens G, Jairath V, Danese S, Chen M, Ghosh S, Hisamatsu T, Kierkus J, Siegmund B, Bragg SM, Crandall W, Durand F, Hon E, Lin Z, Lopes MU, Morris N, Protic M, Carlier H, Sands BE, VIVID Study Group
doi: 10.1016/S0140-6736(24)01762-8
Rheumatoid Arthritis
Association Between Patient-Reported Pain and Remission or Low Disease Activity in Patients with Rheumatoid Arthritis: Data from RA-BE-REAL Prospective Observational Study
Rheumatol Ther
Taylor PC, Fakhouri W, Ogwu S, Haladyj E, de la Torre I, Fautrel B, Alten R, Nash P, Feist E
doi: 10.1007/s40744-024-00732-8
Further Publications Immunology
Association of Cutaneous Immune-related Adverse Events with Overall Survival and Progression-free Survival in Oncology Patients Receiving Immune Checkpoint Inhibitors: A Prospective Study of 189 Patients in a Spanish Tertiary Care Hospital
Acta Derm Venereol
Juan-Carpena G, Martínez Banaclocha N, Palazón Cabanes JC, Niveiro-de Jaime M, Betlloch Mas I, Blanes-Martínez M
doi: 10.2340/actadv.v105.42023